Hanmi Pharmaceutical Group's year-long family feud over management control is poised to end, as a pivotal share transfer shifts power within the founding family. From left: Shin Dong-kuk, chairman ...
Hosted on MSN27d
Hanmi seeks to gain on Wegovy with its own weight-loss drugHanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press conference held in San Francisco, California, on Jan. 15. [LEE JAE-LIM ...
LOS ANGELES, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of ...
Hanmi Financial beat estimated earnings by 9.0%, reporting an EPS of $0.58 versus an estimate of $0.53. Revenue was up $986 thousand from the same period last year. In the previous quarter, the ...
LOS ANGELES, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today reported financial results for ...
Hanmi Financial Corporation announced that it will release its fourth quarter 2024 financial results after the market closes on January 28, 2025. The company's management will hold a conference ...
(RTTNews) - Hanmi Financial Corporation (HAFC) reported a profit for fourth quarter that decreased from last year but beat the Street estimates. The company's earnings came in at $17.70 million ...
SAN FRANCISCO ― Hanmi Pharmaceutical is poised to bring a new chapter to obesity treatment, a topic that has garnered significant attention at this year’s JP Morgan Healthcare Conference.
Hanmi Bank LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback